These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16099147)

  • 21. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.
    Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E
    Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
    Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
    Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum total amylase, pancreatic amylase and lipase activities in epileptic children treated with sodium valproate monotherapy.
    Voudris K; Attilakos A; Katsarou E; Mastroyianni S; Dimou S; Skardoutsou A; Prassouli A; Garoufi A
    Brain Dev; 2006 Oct; 28(9):572-5. PubMed ID: 16730152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of the first antiepileptic drug in the treatment of pediatric epilepsy.
    Ma MS; Ding YX; Ying W; Fang F; Ding CH; Zou LP
    Pediatr Neurol; 2009 Jul; 41(1):22-6. PubMed ID: 19520269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial.
    Gupta M; Aneja S; Kohli K
    Epilepsy Behav; 2004 Jun; 5(3):316-21. PubMed ID: 15145300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective study of 113 epileptic patients treated with sustained-release valproate.
    Despland PA
    Epilepsia; 1994; 35 Suppl 5():S99-100. PubMed ID: 8039482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of antiepileptic drugs in an Omani epileptic population.
    Hanssens Y; Al-Asmi A; Al-Busaidi I; Deleu D
    Clin Neurol Neurosurg; 2006 Sep; 108(6):532-8. PubMed ID: 16169660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
    Pierre-Louis SJ; Brannegan RT; Evans AT
    Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-drug treatment failures in children newly diagnosed with epilepsy.
    Dudley RW; Penney SJ; Buckley DJ
    Pediatr Neurol; 2009 Feb; 40(2):71-7. PubMed ID: 19135617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperammonemia in valproate therapy in children and adolescents].
    Laub MC
    Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes.
    Gupta M; Gupta YK; Agarwal S; Aneja S; Kohli K
    Br J Clin Pharmacol; 2004 Nov; 58(5):542-7. PubMed ID: 15521903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?
    Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H
    Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics.
    Herranz JL; Arteaga R; Adín J; Armijo JA
    Eur J Clin Pharmacol; 2006 Oct; 62(10):805-15. PubMed ID: 16896786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An observational study of first-line valproate monotherapy in focal epilepsy.
    Jedrzejczak J; Kuncíková M; Magureanu S;
    Eur J Neurol; 2008 Jan; 15(1):66-72. PubMed ID: 18042239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of antiepileptic therapy in children (a comparative analysis of valproates and barbiturates)].
    Pylaeva OA; Petrukhin AS; Voronkova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):61-5. PubMed ID: 15554145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment gaps of epilepsy and retention rates of sodium valproate in rural Guangxi, China.
    Huang DH; Zheng JO; Chen J; Yu L
    Genet Mol Res; 2014 Aug; 13(3):6202-12. PubMed ID: 25158247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.